Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;19(3):e216-8.
doi: 10.3747/co.19.940.

Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study

D Rayson  1 , S Lutes, M Sellon, B Colwell, M Dorreen, A Drucker, A Jeyakumar, S Snow, T Younis
Affiliations

Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study

D Rayson et al. Curr Oncol. 2012 Jun.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Incidence distribution of febrile neutropenia events, by cycle. (A) With administration of fec-d (cyclophosphamide–epirubicin–5-fluorouracil, then docetaxel). (B) With administration of tc (docetaxel–cyclophosphamide).
See this image and copyright information in PMC

References

    1. Madarnas Y, Dent SF, Husain SF, et al. Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres. Curr Oncol. 2011;18:119–25. - PMC - PubMed
    1. Roché H, Fumoleau P, Spielmann M, et al. Sequential adjuvant epirubicin-based and docetaxel chemotherapy for nodepositive breast cancer patients: the fnclcc pacs 01 trial. J Clin Oncol. 2006;24:5664–71. doi: 10.1200/JCO.2006.07.3916. - DOI - PubMed
    1. Jones SE, Savin MA, Holmes FA, et al. Phase iii trial comparing doxorubicin plus cyclophosphamide to docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol. 2006;24:5381–7. doi: 10.1200/JCO.2006.06.5391. - DOI - PubMed
    1. Soong D, Haj R, Leung MG, et al. High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide. J Clin Oncol. 2009;27:e101–2. doi: 10.1200/JCO.2009.23.0508. - DOI - PubMed
    1. Myers R, Higgins B, Jeffrey M, et al. Chemotherapy induced febrile neutropenia of docetaxel with cyclophosphamide (tc) for adjuvant therapy of breast cancer in the community—reality check [abstract 2092]. Presented at the San Antonio Breast Cancer Symposium; San Antonio, TX. December 9–11, 2009; [Available online at: http://www.abstracts2view.com/sabcs09/view.php?nu=SABCS09L_848; cited April 21, 2012]

LinkOut - more resources